AKR1B10 and metabolic dysfunction-associated steatohepatitis: The mean plasma level of AKR1B10 was higher in patients with NASH (7629.7 ± 7045.1) than in patients with NAFL (421.7 ± 235.8 pg/mL, p < 0.01) and healthy control subjects (549.8 ± 235.2 pg/mL, p < 0.01).